Final - molecular testing in Dx of cancer Flashcards
(22 cards)
name three diagnostic methods
1) real time PCR
2) DNA sequencing
3) Array
in diagnostic mutation analysis, what is the indicator for a clonal population of B or T cells - PCR technique or capillary-like phoresis
- PCR - a solid band, vs a smear
- phoresis - one peak vs many or curves
what is used to detect HPV and viral pathogens?
- Cobas 4800 system for HPV high volume - nucleic acid isolation
- PCR for head/neck cancers
3 examples of quantitative testing
1) minimal residual disease/tumor burden
2) gene copy number
3) gene expression profiling
what is used for minimal residual disease/tumor burden testing and what is it used for?
CML - initial diagnosis and monitoring therapy?
what is specifically monitored in CML?
- PB values and spleen size
- reduction of Ph+ cells in blood or marrow
- reduction in cells with chromosomal translocation
explain the idea behind personalized medicine
use pharmacogenetic testing to get the right drug early
what was the earliest type of targeted therapy? Examples
- hormonal therapy
- tamoxifen - overexpressed estrogen receptors
- herceptin - when HER-2 gene is amplified
what is EGFR and why is it bad?
- pathogenic cell surface receptor in adenocarcinoma
- growth factor binds to it and initiates a cascade that causes the transcription of more growth factors, some of what promote angiogenesis
what drugs target EGFR?
- monoclonal antibodies – Cetuximab, Panitumumab
- tyrosine kinase inhibitors – Geftinib, Erlotinib
what is used to measure the content of EGFR mutations?
capillary electrophoresis
what are KRAS mutations?
- in 30-50% of all colorectal cancers
- codons 12 and 13, possibly 61
- missense mutations (change in amino acid)
how is a KRAS mutation detected?
- high density microarray
- ion torrent technology
ER
tamoxifen, aromatase inhibitors
HER2
trastuzumab, lapatinib, neratinib, pertuzumab
BCR-ABL
imatinib, dasatinib, nilotinib
EGFR
erlotinib, gefitinib, afatinib, cetuximab
PML-RARa
all trans-retinoic acid
BRAF kinase
vemurafenib
kit kinase
imatinib
PDGFR kinase
imatinib
ALK kinase
crizotinib